Stay updated with breaking news from Lead Discovery Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' powerhouses, the mitochondria.
With guests from politics and science, Max Planck Innovation (MI) was celebrating 50 years of successful technology transfer yesterday in Berlin, after a two-year, pandemic-related, delay. Since the Max Planck subsidiary was founded in 1970, the company has supported more than 4,800 inventions and around 180 company spin-offs, as well as concluding more than 2,900 exploitation agreements. "These science-based spin-offs have created more than 9,250 skilled jobs and contributed to Germany's innovative strength as a business location with their products and services.
Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme Acquisition enables Nodus Oncology to continue building its...
Investegate announcements from Nodus Oncology, Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme
Mini-antibodies efficiently block SARS-CoV-2 virus Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants. These so-called nanobodies bind and neutralize the virus up to 1000 times better than previously developed mini-antibodies. In addition, the scientists optimized their mini-antibodies for stability and resistance to extreme heat. This unique combination makes them promising agents to treat COVID-19. Since nanobodies can be produced at low costs in large quantities, they could meet the global demand for COVID-...